Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study

clinical case reported to report the efficacy of sonidegib in treating laBCCs localized in critical structures the head – neck region, the results reported in patients the complete remission of the with head laBCCs sonidegib the in the Baseline data sex, primary or recurrence and

[1]  I. Zalaudek,et al.  Management of locally advanced basal cell carcinoma treated with sonidegib: The experience of an Italian reference hospital , 2020, Dermatologic therapy.

[2]  G. Fabbrocini,et al.  Complete remission of an advanced basal cell carcinoma after only 3‐month treatment with sonidegib: Report of a case and drug management during COVID‐19 pandemic , 2020, Dermatologic therapy.

[3]  A. Orlandi,et al.  High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature , 2020, Chemotherapy.

[4]  E. Campione,et al.  Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide: A Proof of Concept for Combined Treatments with Hedgehog Inhibitors in Advanced Basal Cell Carcinoma , 2020, Biomedicines.

[5]  G. Fabbrocini,et al.  Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma , 2020, Dermatology and Therapy.

[6]  A. Hauschild,et al.  Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  G. Fabbrocini,et al.  Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) , 2019, Dermatology and Therapy.

[8]  S. Ibrahim,et al.  Oral Hedgehog Pathway Inhibition as a Means for Ocular Salvage in Locally Advanced Intraorbital Basal Cell Carcinoma , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  D. Ratner,et al.  Implementation of Systemic Hedgehog Inhibitors in Daily Practice as Neoadjuvant Therapy. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.